ArticleCureus2026
Early Dissecting Cellulitis of the Scalp Following Repeated Microinfusion of Medication Into the Skin in a Patient With Androgenetic Alopecia and Long-Term Exogenous Testosterone Use: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dissecting cellulitis of the scalp is an uncommon chronic inflammatory disorder within the follicular occlusion spectrum and may progress to permanent cicatricial alopecia if not recognized early. We report a case of a 34-year-old male with androgenetic alopecia, two years of exogenous testosterone use, and a recent history of six-monthly sessions of scalp microinfusion of medication into the skin, who developed painful and pruritic inflammatory scalp nodules approximately 45 days after the last procedure. The procedure was performed using a Cheyenne Unlimited 4 dermograph fitted with a 2710MG cartridge, corresponding to a 27-needle magnum configuration with 0.30 mm diameter needles, operating at 6.1 V, with the needle depth set to 1.2 mm. Clinical examination showed focal inflammatory alopecic nodules over a background of patterned hair thinning. Trichoscopy demonstrated perifollicular erythema, reduced follicular density, broken hairs, black dots, white structureless areas, and partial preservation of follicular openings, without classic features of alopecia areata. Histopathology showed hypodermal granulation tissue, intense mixed leukocytic inflammation composed of lymphocytes, plasma cells, neutrophils, macrophages, and foreign body-type multinucleated giant cells, follicular involvement with miniaturization, negative periodic acid-Schiff staining for fungi, and bacterial colonization in the infundibular and isthmic portions of hair follicles. These findings were consistent with dissecting folliculitis of the scalp. The patient was treated with oral antibiotics, intralesional corticosteroid, and high-potency topical corticosteroid, with partial inflammatory improvement and stabilization. This case highlights the value of clinicotrichoscopic-pathologic correlation in early dissecting cellulitis and raises the possibility that repeated procedural microtrauma, barrier disruption, follicular injury, or secondary bacterial colonization may act as a local trigger in a predisposed patient. The long-term exogenous testosterone exposure should be interpreted as a possible modifying factor rather than proof of causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.